Showing results (111-120 of 210) with videos related to
Sort By:
Pageof 21
Rheumatology and Immunology Research|December 5, 2022
Effectiveness of SB4 Transition from Originator Etanercept in Rheumatoid Arthritis and Axial Spondyloarthritis: A Subgroup Analysis from the BENEFIT StudyNicoletta Luciano, Enrico Fusaro, Maria Chiara Ditto, et al.Journal of Translational Autoimmunity|December 11, 2020
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled studyLuca Quartuccio, Miriam Isola, Dario Bruno, et al.Plos One|August 4, 2012
Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesisGianfranco Ferraccioli, Barbara Tolusso, Francesca Bobbio-Pallavicini, et al.The Journal of Rheumatology|April 3, 2012
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictorsFlorenzo Iannone, Elisa Gremese, Fabiola Atzeni, et al.Annals of Laboratory Medicine|October 26, 2019
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of ImmunogenicityMaurizio Benucci, Valentina Grossi, Mariangela Manfredi, et al.Annals of the Rheumatic Diseases|February 2, 2012
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosusDomenico Frezza, Barbara Tolusso, Vincenzo Giambra, et al.The World Allergy Organization Journal|July 24, 2023
Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysisCristiano Caruso, Stefania Colantuono, Barbara Tolusso, et al.Annals of the Rheumatic Diseases|February 25, 2022
Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio StudyLaure Gossec, Stefan Siebert, Paul Bergmans, et al.Frontiers in Medicine|September 6, 2021
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid ArthritisGabriele Di Sante, Elisa Gremese, Barbara Tolusso, et al.Journal of Clinical Medicine|December 23, 2022
Axial Spondyloarthritis: Reshape the Future-From the "2022 GISEA International Symposium"Fausto Salaffi, Cesare Siragusano, Alessandra Alciati, et al.Pageof 21